Publication Cover
Physiotherapy Theory and Practice
An International Journal of Physical Therapy
Volume 37, 2021 - Issue 12
263
Views
3
CrossRef citations to date
0
Altmetric
Research Report

Randomized feasibility study of twice a day functional electrostimulation in patients with severe chronic obstructive pulmonary disease hospitalized for acute exacerbation

, MSc, PT, , PhD, PT, , MSc, PT, , PhD, PT, , PhD, PT & , PhD, PT
Pages 1360-1367 | Received 27 Sep 2018, Accepted 15 Oct 2019, Published online: 26 Nov 2019
 

ABSTRACT

Introduction:Pulmonary rehabilitation is an effective intervention for individuals who have Chronic Obstructive Pulmonary Disease (COPD). The adequate intensity, components, and number of sessions are difficult to determine, specifically in patients who have severe ventilatory limitations in order to produce true physiological training effects without adverse events. Objective:Our aim is to assess the feasibility and possible effects of a daily versus a twice-daily functional electrostimulation program in hospitalized individuals who have a severe COPD. Methods:In this randomized controlled trial, 48 severe patients with COPD were randomized into three groups: Control Group (CG; n = 16), daily functional electrostimulation group (DFEG; n = 15) or twice-daily functional electrostimulation group (TFEG; n = 17). The main outcome measures were quadriceps strength, symptoms at rest and after exercise, and adverse events measured before and after the intervention. Results:After eight sessions, DFEG and TFEG showed significant differences when compared to the CG in all measured variables at discharge (p ≤ .001), no adverse events were observed in any of the treatment groups. Significant improvements were found in strength (p ≤ .05) between DFEG and TFEG groups. However, lower limb function did not present significant differences in spite of the fact that the mean change favored the TFEG (23.53 ± 3.53 vs. 19.56 ± 11.89). Conclusion:Further examination of twice per day functional electrostimulation in hospitalized patients with COPD with acute exacerbation appears warranted.

Acknowledgments

This work was financed jointly by Fundación Progreso y Salud (FPS) and Boehringer Ingelheim España, SA. Project code: PI-0370-2014. Oximesa, Praxair.

Disclosure statement

The authors declare that there are no conflicts of interest.

Additional information

Funding

This work was supported by the FPU (‘Formación Profesorado Universitario’) grant (FPU: 17/00408) of the Spanish Ministry of Education.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 325.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.